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We appreciate the interest of Dr. Karamanoukian and colleagues
in our study about the relation between postoperative stroke in
cardiac surgery and presence, location and extent of atherosclerosis
in the ascending aorta (1). Our study showed a 3.5% incidence of
stroke due to atherosclerosis of the ascending aorta as detected by
epiaortic ultrasound (in 26% of the patients) despite minor surgical
modifications. Furthermore, a multivariate analysis showed that
the two best predictors for perioperative stroke were atherosclerosis
of the ascending aorta and diabetes mellitus. Age is usually
associated with atherosclerosis in the ascending aorta. Conse-
quently, atherosclerosis of the ascending aorta (detected by intra-
operative ultrasound) is a better predictor than age. Therefore, we
recommended a more radical change in surgical strategy in the
presence of atherosclerosis of the ascending aorta, and especially
when the disease of the aortic wall is extended.
One interesting option in this situation is off-pump coronary
artery bypass (OPCAB). Still, partial clamping of the ascending
aorta is usually used in OPCAB. Clamping of the ascending aorta
has been shown to generate cerebral emboli (2–5). Thus, with
OPCAB cross-clamping can be avoided, but usually partial clamp-
ing is conducted, unless an anastomotic device is employed or the
ascending aorta is totally avoided. A further possibility is the use of
intraoperative intraaortic filters, if clamping is necessary (5).
We congratulate Dr. Karamanoukian and colleagues for their
successful results with OPCAB in octogenarians. Notably, approx-
imately 12% of their patient cohort had atherosclerosis of the
ascending aorta, presumably detected by palpation. It is unclear
how these patients were handled in terms of proximal anastomosis
on the ascending aorta. Considering that their patients received
only on average 1.8 grafts, we assume that their conclusion should
be that OPCAB incomplete revascularization without touching
the ascending aorta may be the preferred operative technique in
high-risk patients (i.e., octogenerians).
Recently, we employed OPCAB to achieve complete revascu-
larization in 20 patients with extensive disease of the ascending
aorta according to intraoperative ultrasound and totally avoided the
ascending aorta in the majority of the patients. None of the 20
patients suffered a perioperative stroke.
In conclusion, we believe that OPCAB techniques may have a
justified place in high-risk patients (i.e., with extended atheroscle-
rosis the ascending aorta according to epiaortic ultrasound) in
order to prevent perioperative stroke. However, well-designed
randomized studies have to be conducted to prove the superiority
of OPCAB over conventional coronary surgery.
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Cytokine Gene Polymorphisms
and Development of
CAD Associated With CP Infection
We read with great interest the study by Momiyama et al. (1) in a
recent issue of the Journal. The study reports that cytokine gene
polymorphisms, in particular interleukin-1 (IL-1) polymorphisms,
play a role in the development of coronary artery disease (CAD) in
patients with Chlamydia pneumoniae (CP) infection. Moreover,
they found that CP seropositivity was not significantly different
between patients with and without CAD. Momiyama et al. (1)
suggested that “triggers” such as IL-1 gene polymorphisms could
influence the effect of such infectious agents as CP on development
of CAD.
Increasing evidence exists indicating that inflammation plays an
important role in atherogenesis (2). The hypothesis of infectious
agents that might play an important role in the atherogenesis is
supported by results of several epidemiologic studies suggesting
possible atherogenic potential not only from CP (3) but also from
such pathogens as cyotmegalovirus (4), herpes simplex virus (HSV)
(5) and Helicobacter pylori (6).
However, existing epidemiologic data about the association of
some of these pathogens and atherosclerosis are conflicting (7). We
support the finding of Momiyama et al. (1) that that CP seropos-
itivity is not associated with CAD by data from 218 consecutive
patients undergoing coronary angiography. Blood of all subjects
was tested for serum IgG antibodies to CP and for seromarkers of
five other pathogens (hepatitis A-virus, Helicobacter pylori, HSV,
influenza type A and influenza type B). Of the 218 patients, 88
(40.4%) had anti-CP IgG antibodies. The CAD prevalence was
61.4% in CP-seropositive and 66.9% in CP-seronegative patients
(p  0.49). Moreover, seropositivity for each other pathogen
(tested in our study) was not associated with CAD.
In contrast, the number of infectious pathogens to which an
individual has been exposed (8) (“infectious burden”) correlates
with prevalence of CAD. Four or more of the six seromarkers
tested for particular infections were positive in 48.8% of patients
with CAD and in 31.2% of patients in patients without CAD (p
0.02). Therefore, our data support the results from Momiyama et
al. (1) that seropositivity for a particular infectious agent, like CP,
represents no predictor of risk for CAD. However, some “triggers,”
such as cytokine gene polymorphisms or additional exposure to
918 Letters to the Editor JACC Vol. 39, No. 5, 2002
March 6, 2002:916–21
other pathogens, could influence the susceptibility to the athero-
genic effect of infection with a particular pathogen like CP.
Consequently, this finding suggests that “susceptibility” factors
could make subjects more likely to develop CAD when infected
with a particular pathogenic agent.
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We greatly appreciate the comments of Dr. Auer and colleagues
regarding our article recently published in the Journal of the
American College of Cardiology (1).
Chlamydia pneumoniae (CP) was often reported to be associated
with coronary artery disease (CAD) in seroepidemiologic studies,
but the potential contribution of CP to CAD remains controver-
sial. As shown in our article (1), Auer et al. also found no
significant difference in the CAD prevalence between patients with
and without CP seropositivity. However, CP organism was de-
tected within atheroma by direct immunofluorescence and poly-
merase chain reaction (PCR), and CP infection was shown to
accelerate atherosclerosis in a rabbit model. We agree with Dr.
Auer and colleagues that some triggers like cytokine gene poly-
morphisms or additional exposure to other pathogens could
influence susceptibility to the atherogenic effect of CP infection.
Regarding genetic factors for CAD associated with CP infec-
tion, we reported that two polymorphisms of interleukin (IL)-1
genes play a role in the development of CAD, especially myocar-
dial infarction, in patients with CP infection (1). However, other
cytokine gene polymorphisms, such as IL-6 and IL-10, were also
reported to be associated with CAD as well as inflammatory
diseases. In addition to the IL-1 gene polymorphisms, they may be
contributing to the development of CAD associated with CP
infection. We will continue to seek genetic factors influencing the
susceptibility to CAD associated with CP or other infections.
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Patients With CHF and Depression
Have Greater Risk of Mortality and
Morbidity Than Patients Without Depression
With great respect and interest, we read the recently published
study by Vaccarino et al. (1) in the Journal. That study supports our
previous findings, presented at the annual meetings of the Amer-
ican Psychiatric Association (2) and the American Heart Associ-
ation (3) and was just published a day before in the Archives of
Internal Medicine this month, that the short-term prognosis of
patients with heart failure (HF) and comorbid depression is much
worse than that of such patients without depression.
Vaccarino and colleagues assessed the level of depressive symp-
toms by means of the Geriatric Depression Scale (GDS) on 391
patients aged 50 or older who were hospitalized with HF. They
followed the patients for six months and assessed mortality and
functional capacity in activities of daily living (ADL). They found
that mortality at six months was two to three times higher in
patients with greater depressive symptoms than in those with lesser
depressive symptoms or those considered to have normal mood.
Patients with moderate to severe depressive symptoms also showed
significant functional declines during follow-up. Apparently, the
covariates of age, gender, race and education were not associated
with the relationships of depression to mortality and functional
decline; but when the statistical model was adjusted for other
variables, such as prior infarction, diabetes, prior admission for
HF, certain limiting factors of ADL and several baseline clinical
features (systolic blood pressure, serum creatinine, pulse and left
ventricular ejection fraction), in addition to these demographic
characteristics, the adverse relation between depression and mor-
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